Study S001226

The Danish Trial of Weight Loss to Reduce Atrial Fibrillation Progression

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07816744
Acronym: DANWRAP
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: SINGLE
Status: NOT_YET_RECRUITING
Enrollment: 480
Start: 2026-10-01
Primary completion: 2030-04
Lead sponsor: Axel Brandes
Conditions: Atrial Fibrillation (AF); Obesity & Overweight
Interventions: OTHER:Structured weight loss program including behavioral support and optional meal re-placement or pharmacotherapy with Glucagon-like peptide-1 receptor agonists (GLP1-RA); OTHER:Standard Care (in control arm)
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Hierarchical composite outcome capturing AF progression and AF burden, inte-grating clinical events assessed by blinded adjudication and objective measures of AF burden, assessed by 14-day continuous ECG monitoring [From 4 months to 12 months after enrollment]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.